We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

Global Cancer Services Market Outlook 2030: Market Segmentation Based on Preventive Care Services, Based on Diagnostic Care Services, Based on Application, Based on End-User, With COVID-19 impact | Forecast Period 2017-2030

Published Date :

2020-09-01

Report Pages :

750

Format :

PDF

Region Covered :

Global

Global Cancer Services Market Overview

In 2015, as per World Health Organization (WHO), 8.8 million deaths were recorded due to cancer and around 20 million people in the world are suffering from cancer. Around 30% people died from cancer caused by tobacco every year. North America and Europe has registered maximum number of cases suffering from lung cancer due to wide adoption of smoking habit. Asia-Pacific region is rapidly expanding in lung cancer cases due to increasing habit of cigarette smoking. Countries of Eastern Europe and other countries like Chile, northern China and Japan have significant number of people suffering from stomach cancer. Increasing number of deadly disease is creating the need for better cancer services. The surge of innovative cancer treatment are becoming a global traction and increasing the demand for cancer services market.

One-third of the 10 million cancer cases can be reduced across the world by taking preventive measures and increasing awareness amongst people. Cancer preventive measures have shown increment in the survival rate from 48% to more than 60% over last two decades. Technological innovations and quality care offerings by non-profitable organizations are creating awareness among people and are likely to boost the demand for better cancer services in near future.

Global Cancer Services Market Segmentation

Global Cancer Services Market is categorized on the following basis:

  • Based on Preventive Care Services
    • By Vaccines
    • By Cancer Growth Inhibitors
  • Based on Diagnostic Care Services
    • By Diagnostic Tests
    • By Biopsy
    • By Endoscopy
    • By Imaging
    • By Cancer Therapies
  • Based on Application
    • Blood Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Kidney Cancer
    • Lungs cancer
    • Other Application (Skin Cancer, Gastrointestinal Tract Cancer, Liver Cancer)
  • Based on End-User
    • Cancer Hospitals
    • Diagnostic Centers
    • Special Clinics
  • Based on Geography
    • North America (U.S. & Canada) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
    •  Latin America (Brazil, Mexico & Rest of Latin America)        {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
    • Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
    • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
    • Middle East & Africa (GCC, South Africa, North Africa, RoMEA) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
    •  Rest of World {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}

Market Size and Forecast (2017-2030)

The global cancer services market is projected to grow at a CAGR of 15.7% whereas global cancer therapy market is anticipated to grow at CAGR of 16.7% during the forecast period of 2017-2030.

North America holds 45% revenue share of global cancer services market in 2016 followed by Europe and is expected to dominate during the forecast period. Every year nearly 24% deaths in North America are caused by cancer. Rising adoption of innovative treatment technology, advanced therapies and government reimbursement policies are the key factors driving the cancer services market in North America region. In 2014, nearly USD 100 billion was spent on oncology medicines globally out of which North America and Europe together accounted for more than 65% of total spending. Europe cancer services market valued USD 32.8 billion in 2015 and is expected to grow at a CAGR of 15.0% during the forecast period.

Rising prevalence of lungs and oral cancer in the region is supporting the growth for cancer services market in Asia-Pacific region. Large number of patients diagnosed with lungs and oral cancer are from developing countries such as India and China. Asia-Pacific cancer services market valued USD 15.3 billion in 2016. Rising number specialty centers in Asian countries are likely to propel the demand for cancer services market in the region. For instance, India has over 300 special centers for cancer care and 27 dedicated hospitals for cancer treatment. However, Asian market is growing at a slow pace due to declining rate of GDP spend on healthcare in low income group countries such as Afghanistan, Turkmenistan, Armenia, Bhutan and Uzbekistan.

Latin America (LA) and Middle East & Africa (MEA) region are also witnessing low level growth for cancer services market due to lack of availability of medical facilities. As per WHO, LA and MEA together accounted for 11.2% of total deaths caused by cancer. 

Market Drivers and Challenges

High frequency of death due to cancer is increasing the awareness among people. Huge investment in healthcare and R&D, innovative treatment facilities and government reimbursement policies are bolstering adoption of the cancer services across the globe. Moreover, introduction of cancer preventive programs are also helping in rising demand for cancer services market. As per WHO, 48% of cancer control policy plan has been successfully executed globally.

However, high cost of cancer treatments restricting the growth of cancer services mainly in emerging economies. Lack of awareness among population majorly in developing countries about clinical trials is also a major barrier to slow down the growth rate of cancer services market.

Opportunities

  • Use of big data in clinical trials is expected to improve the way of cancer care services. Moreover, innovative treatments and therapies are expected to increase the survival rate
  • Initiatives to provide quality care delivery in a cost effective way can increase the adoption rate of cancer services. Local and regional players can have huge opportunities in providing cancer services at reasonable cost.
  • Recent advancement in radiation oncology such as IMRT, IGRT and robotic radiotherapy can provide better cancer treatment in the near future.

Risk Factors

  • Less effective result of treatment in final stage of cancer is a major threat to the cancer services market.
  • Side effects of chemotherapy and radiation therapy are decreasing the market demand.
  • Diagnosis of cancers of unknown origin is a major challenge in oncology treatment.

Covered in this Global Cancer Services Market Report 

Market Synopsis

Market Segmentation

The Global Cancer Services Market is segmented as follows:

  • By Prevent Care Services (Market Size, Demand Analysis and Growth Analysis)
  • By Diagnostic Care Services (Market Size, Demand Analysis and Growth Analysis)
  • By Application (Market Size, Demand Analysis and Growth Analysis)
  • By End-User (Market Size, Demand Analysis and Growth Analysis)

By Regions

  • North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
  • Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
  • Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
  • Asia-Pacific (China, India, Singapore, Japan, Hong-Kong, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}
  • Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
  • Rest of World  {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

  • Risk Factors
  • Regional Variations
  • Recent Trends and Developments

COVID-19 imapct on "Global Cancer Services Market"    

Impact of COVID-19 Outbreak on “Global Cancer Services Market”, Manufacturers, Contract Manufacturers Suppliers and Recovery Strategy. A complete detailed chapter of 50-70 pages which includes the data and information focused on impacts of the pandemic on the Global Cancer Services Market. It also showcases the expected recovery schedule and losses in the industry and other various major factors.

Key Market Players

  • GE Healthcare
  • Synopsis
  • Business Strategy
  • Product Portfolio
  • SWOT Analysis
  • Philips Healthcare
  • Siemens Healthcare
  • Novartis
  • Abbott Diagnostics
  • Roche
  • Pfizer Inc.
  • Sanofi
  • Amgen
  • Merck & Co.
  • GlaxoSmithKline
  • Johnson & Johnson
  • Amgen Inc.
  • Eli Lilly and Company
  • Hoffman La-Roche Ltd.
  • Roche Holdings Ltd.

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks




{

Global Cancer Services Market- Table of Content

 

1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Data Analyzing & Market Size Estimation 
1.4. Research Design
1.5. Bottom-Up & Top-Down Approach
 
2. Market Environment
2.1. India Economic Overview
2.2. Macroeconomic Outlook
2.3. Healthcare sector Overview
2.4. Population & Age Distribution
2.5. Historical Market Trends
 
3. Regional Industry Analysis 
3.1. Trends in Health Care
3.1.1. Medical Conditions
3.1.2. Health Insurance Coverage
3.1.3. National Health Expenditures
3.2. Trends in IVD Testing
3.2.1. Cancer Tests by Technology
3.2.2. Cancer Testing Sites
3.3. Research & Development Outlook
3.4. Acquisitions & Divestitures
3.5. Competitive Strategies
 
4. Executive Summary
4.1. Market Size (USD Million)
4.2. Forecast Analysis (2016-2024)
4.3. Market Share & CAGR (%)
4.4. Regional Share Distribution (%)
 
5. Market Dynamics
5.1. Growth Drivers
5.2. Market Restraints
5.3. Risk Analysis (Demand Risk & Supply Risk Analysis)
5.4. Recent Trends & Developments
5.5. Opportunities for Market Players
 
6. Global Cancer Services Market  Segmentation
6.1. Global Cancer Services Market By Preventive Care Services  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.1. Vaccines For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.2. Cancer Growth Inhibitors For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.3. Market Attractiveness by Preventive Care Services
6.1.4. BPS Analysis by Preventive Care Services
 
6.2. Global Cancer Services Market By Diagnostic Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.1. Diagnostic TestsFor Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.2. Biopsy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.3. Endoscopy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.4. Imaging For Cancer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.5. Cancer Therapies Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.6. Market Attractiveness by Diagnostic Care Services
6.2.7. BPS Analysis by Diagnostic Care Services
 
6.3. Global Cancer Services Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1. Cancer Services for Blood Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2. Cancer Services for Breast Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3. Cancer Services for Colorectal Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4. Cancer Services for Kidney Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5. Cancer Services for Lungs Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.6. Cancer Services for Other Application (Skin Cancer, Gastrointestinal Tract Cancer, Liver Cancer)  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.7. Market Attractiveness by Application
6.3.8. BPS Analysis by Application
 
6.4. Global Cancer Services Market By End-User
6.4.1. Cancer Hospitals Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.2. Diagnostic Centers For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.3. Special Clinics For Cancer ServicesMarket  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.4. Market Attractiveness by End-User
6.4.5. BPS Analysis by End-User
 
6.5. Global Cancer Services Market By Region (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.1. North America Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.1. North America Cancer Services Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.1.1.1. U.S. Cancer Services Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.1.2. Canada Cancer Services Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.1.3. Market Attractiveness by Country
6.5.1.1.4. BPS Analysis by Country
 
6.5.1.2. North America Cancer Services Market By Preventive Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.1. Vaccines For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.2. Cancer Growth Inhibitors For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.3. Market Attractiveness by Preventive Care Services
6.5.1.2.4. BPS Analysis by Preventive Care Services
6.5.1.3. North America Cancer Services Market  By Diagnostic Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.1. Diagnostic Tests For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.2. Biopsy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.3. Endoscopy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.4. Imaging For Cancer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.5. Cancer Therapies Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.6. Market Attractiveness by Diagnostic Care Services
6.5.1.3.7. BPS Analysis by Diagnostic Care Services
 
6.5.1.4. North America Cancer Services Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.1. Cancer Services for Blood Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.2. Cancer Services for Breast Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.3. Cancer Services for Colorectal Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.4. Cancer Services for Kidney Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.5. Cancer Services for Lungs Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.6. Cancer Services for Other Application (Skin Cancer, Gastrointestinal Tract Cancer, Liver Cancer)  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.7. Market Attractiveness by Application
6.5.1.4.8. BPS Analysis by Application
 
6.5.1.5. North America Cancer Services Market By End-User
6.5.1.5.1. Cancer Hospitals Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.5.2. Diagnostic Centers For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.5.3. Special Clinics For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.5.4. Market Attractiveness by End-User
6.5.1.5.5. BPS Analysis by End-User
 
6.5.2. Europe Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1. Europe Cancer Services Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.2.1.1. UK  Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.2. France Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.3. Italy Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.4. Germany Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.5. Spain Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.6. Hungary Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.7. Sweden Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.8. Russia Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.9. Poland Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.10. Rest of Europe Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.11. Market Attractiveness by Country
6.5.2.1.12. BPS Analysis by Country
 
6.5.2.2. Europe Cancer Services Market By Preventive Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.1. Vaccines For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.2. Cancer Growth Inhibitors For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.3. Market Attractiveness by Preventive Care Services
6.5.2.2.4. BPS Analysis by Preventive Care Services
 
6.5.2.3. Europe Cancer Services Market  By Diagnostic Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.1. Diagnostic Tests For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.2. Biopsy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.3. Endoscopy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.4. Imaging For Cancer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.5. Cancer Therapies Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.6. Market Attractiveness by Diagnostic Care Services
6.5.2.3.7. BPS Analysis by Diagnostic Care Services
 
6.5.2.4. Europe Cancer Services Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.1. Cancer Services for Blood Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.2. Cancer Services for Breast Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.3. Cancer Services for Colorectal Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.4. Cancer Services for Kidney Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.5. Cancer Services for Lungs Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.6. Cancer Services for Other Application (Skin Cancer, Gastrointestinal Tract Cancer, Liver Cancer)  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.7. Market Attractiveness by Application
6.5.2.4.8. BPS Analysis by Application
 
6.5.2.5. Europe Cancer Services Market By End-User
6.5.2.5.1. Cancer Hospitals Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.5.2. Diagnostic Centers For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.5.3. Special Clinics For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.5.4. Market Attractiveness by End-User
6.5.2.5.5. BPS Analysis by End-User
 
6.5.3. Middle East & Africa Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1. Middle East & Africa Cancer Services Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.3.1.1. Gulf Cooperation Council Countries (GCC) Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1.2. South Africa Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1.3. North Africa Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1.4. Rest of Middle East and Africa Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1.5. Market Attractiveness by Country 
6.5.3.1.6. BPS Analysis by Country
 
6.5.3.2. Middle East & Africa Cancer Services Market By Preventive Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.1. Vaccines For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.2. Cancer Growth Inhibitors For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.3. Market Attractiveness by Preventive Care Services
6.5.3.2.4. BPS Analysis by Preventive Care Services
 
6.5.3.3. Middle East & Africa Cancer Services Market  By Diagnostic Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.1. Diagnostic Tests For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.2. Biopsy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.3. Endoscopy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.4. Imaging For Cancer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.5. Cancer Therapies Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.6. Market Attractiveness by Diagnostic Care Services
6.5.3.3.7. BPS Analysis by Diagnostic Care Services
 
6.5.3.4. Middle East & Africa Cancer Services Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.1. Cancer Services for Blood Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.2. Cancer Services for Breast Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.3. Cancer Services for Colorectal Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.4. Cancer Services for Kidney Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.5. Cancer Services for Lungs Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.6. Cancer Services for Other Application (Skin Cancer, Gastrointestinal Tract Cancer, Liver Cancer)  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.7. Market Attractiveness by Application
6.5.3.4.8. BPS Analysis by Application
 
6.5.3.5. Middle East & Africa Cancer Services Market By End-User
6.5.3.5.1. Cancer Hospitals Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.5.2. Diagnostic Centers For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.5.3. Special Clinics For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.5.4. Market Attractiveness by End-User
6.5.3.5.5. BPS Analysis by End-User
6.5.4. Latin America Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.1. Latin America Cancer Services Market  By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.4.1.1. Brazil Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.1.2. Mexico Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.1.3. Rest of Latin America Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.1.4. Market Attractiveness by Country 
6.5.4.1.5. BPS Analysis by Country
 
6.5.4.2. Latin America Cancer Services Market By Preventive Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.1. Vaccines For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.2. Cancer Growth Inhibitors For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.3. Market Attractiveness by Preventive Care Services
6.5.4.2.4. BPS Analysis by Preventive Care Services
 
6.5.4.3. Latin America Cancer Services Market  By Diagnostic Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.1. Diagnostic Tests For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.2. Biopsy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.3. Endoscopy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.4. Imaging For Cancer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.5. Cancer Therapies Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.6. Market Attractiveness by Diagnostic Care Services
6.5.4.3.7. BPS Analysis by Diagnostic Care Services
 
6.5.4.4. Latin America Cancer Services Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.1. Cancer Services for Blood Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.2. Cancer Services for Breast Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.3. Cancer Services for Colorectal Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.4. Cancer Services for Kidney Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.5. Cancer Services for Lungs Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.6. Cancer Services for Other Application (Skin Cancer, Gastrointestinal Tract Cancer, Liver Cancer)  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.7. Market Attractiveness by Application
6.5.4.4.8. BPS Analysis by Application
 
6.5.4.5. Latin America Cancer Services Market By End-User
6.5.4.5.1. Cancer Hospitals Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.5.2. Diagnostic Centers For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.5.3. Special Clinics For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.5.4. Market Attractiveness by End-User
6.5.4.5.5. BPS Analysis by End-User
 
6.5.5. Asia Pacific (APAC) Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1. Asia Pacific Cancer Services Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.5.1.1. China Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.2. Japan Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.3. India Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.4. Singapore Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.5. South Korea Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.6. Australia Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.7. New Zealand Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.8. Rest of Asia-Pacific Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.9. Market Attractiveness by Country 
6.5.5.1.10. BPS Analysis by Country
 
6.5.5.2. Asia-Pacific Cancer Services Market By Preventive Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.1. Vaccines For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.2. Cancer Growth Inhibitors For Cancer Treatment Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.3. Market Attractiveness by Preventive Care Services
6.5.5.2.4. BPS Analysis by Preventive Care Services
 
6.5.5.3. Asia-Pacific Cancer Services Market  By Diagnostic Care Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.1. Diagnostic Tests For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.2. Biopsy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.3. Endoscopy For Cancer Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.4. Imaging For Cancer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.5. Cancer Therapies Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.6. Market Attractiveness by Diagnostic Care Services
6.5.5.3.7. BPS Analysis by Diagnostic Care Services
 
6.5.5.4. Asia-Pacific Cancer Services Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.1. Cancer Services for Blood Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.2. Cancer Services for Breast Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.3. Cancer Services for Colorectal Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.4. Cancer Services for Kidney Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.5. Cancer Services for Lungs Cancer  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.6. Cancer Services for Other Application (Skin Cancer, Gastrointestinal Tract Cancer, Liver Cancer)  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.7. Market Attractiveness by Application
6.5.5.4.8. BPS Analysis by Application
 
6.5.5.5. Asia-Pacific Cancer Services Market By End-User
6.5.5.5.1. Cancer Hospitals Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.5.2. Diagnostic Centers For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.5.3. Special Clinics For Cancer Services Market  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.5.4. Market Attractiveness by End-User
6.5.5.5.5. BPS Analysis by End-User
 
7. Competitive Outlook
7.1. Market Share of Major Players (2016)
7.2. Company Profiles
7.2.1. GE Healthcare
7.2.1.1. Company Synopsis
7.2.1.2. Business Strategy
7.2.1.3. Product Portfolio
7.2.1.4. SWOT Analysis
7.2.2. Philips Healthcare
7.2.3. Siemens Healthcare
7.2.4. Novartis
7.2.5. Abbott Diagnostics
7.2.6. Roche
7.2.7. Pfizer Inc.
7.2.8. Sanofi
7.2.9. Amgen
7.2.10. Merck & Co.
7.2.11. GlaxoSmithKline
7.2.12. Johnson & Johnson
7.2.13. Amgen Inc.
7.2.14. Eli Lilly and Company
7.2.15. Hoffman La-Roche Ltd.
7.2.16. Roche Holdings Ltd.
 
8. Porter’s Five Force Model
9. Market Landscape: Competition and Beyond
10. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
11. Expert Analysis
12. Concluding Remarks
}

Global Cancer Services Market Outlook 2030: Market Segmentation Based on Preventive Care Services, Based on Diagnostic Care Services, Based on Application, Based on End-User, With COVID-19 impact | Forecast Period 2017-2030

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

Please Select Linenece Type